Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Announcement XORTX Therapeutics Inc., a leading late-stage clinical pharmaceutical company aiming to establish innovative therapies for the treatment of progressive kidney and gout diseases, unveiled...
Announcement Cogent Biosciences, Inc., a leading biotechnology company dedicated to establishing accurate therapies for genetically defined diseases, has now submitted its promising New Drug Applicat...
Recap Tiger BioSciences spotlights the number of important and valuable scientific and clinical advances that have been made from the company’s extensive investment in proof-based research acro...
Announcement Autonomix Medical, Inc., a known medical device company devoted to modernising the accurate nerve-focused treatments, have received an official patent right from the European Patent Offi...
Announcement Sinopia Biosciences, Inc., a leading biotechnology company known for modernising novel therapeutics with the help of its exclusive LEADS® drug discovery platform, proudly declared th...
Announcement Johnson & Johnson, the popular company, has completed its acquisition of Halda Therapeutics OpCo, Inc., a known clinical-level biotechnology company. Along with this acquisition, Joh...
Announcement SELLAS Life Sciences Group, Inc., a leading late-stage clinical biopharmaceutical company focused on the establishment of novel therapies for a wide range of cancer indications have an u...
Announcement Co-Diagnostics, Inc., a leading molecular diagnostics company with a remarkable patented platform for the establishment of molecular diagnostics tests, today proudly announced that it ha...
Announcement WORK Medical Technology Group LTD, a well-known provider of medical devices in China, operates via its branch named Work (Hangzhou) Medical Treatment Equipment Co., Ltd and its other bra...
Announcement Caliway, a leading biopharmaceutical company, proudly announced its submission of an Investigational New Drug (IND) application to the US FDA for its robust Phase 2 clinical study of its...
Speak with a healthcare analyst about your research, consulting, or platform needs.